AbbVie (ABBV) released earnings for second quarter that Decreased from last year but beat the Street estimates.
The company's earnings totaled $938 million, or $0.52 per share. This compares with $1.370 billion, or $0.77 per share, last year.
Excluding items, AbbVie reported adjusted earnings of $5.278 billion or $2.97 per share for the period.
Analysts on average had expected the company to earn $2.91 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 6.6% to $15.423 billion from $14.462 billion last year.
AbbVie earnings at a glance (GAAP) :
-Earnings: $938 Mln. vs. $1.370 Bln. last year.-EPS: $0.52 vs. $0.77 last year.-Revenue: $15.423 Bln vs. $14.462 Bln last year.
Looking ahead, Robert A. Michael, CEO of AbbVie, said: "We're entering the second half of the year with substantial momentum and are once again raising our full-year outlook."
For the full year, AbbVie has revised up its earnings outlook, in line with Street view. The company now anticipates adjusted income of $11.88 to $12.08 per share, higher than the earlier outlook of $11.67 to $11.87 per share.
Analysts, on average, forecast the firm to earn $11.98 per share for the year.
For fiscal 2024, the company had recorded adjusted income of $10.12 per share.
ABBV was up by 3.46% at $195.94 in the pre-market trade on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.